Musculoskeletal Problems and Strategies Developed by Physiotherapists to Cope With Them

June 14, 2024 updated by: Dr. Öğr. Üyesi Ömer Şevgin, Uskudar University

Comparison of Physiotherapists Working in Different Fields in Terms of Occupational Satisfaction, Burnout, Musculoskeletal System Problems and the Strategies They Developed to Cope With it.

The aim of this study is to investigate whether there is a difference in areas such as occupational musculoskeletal injuries and strategies developed by physiotherapists working in different fields, burnout and occupational satisfaction.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study is a descriptive, cross-sectional online survey study. In this study, it is aimed to reach people who have graduated from the Physiotherapy and Rehabilitation Departments of the Faculties of Health Sciences or the Physical Therapy and Rehabilitation Schools of universities in Turkey, which provide education for 4 years and have the title of "physiotherapist". Physiotherapists will be divided into 5 groups according to the fields they work. Group 1 is only pediatric patients, Group 2 is orthopedics and sportsman, Group 3 is neurology and intensive care, Group 4 is general group that receives patients in many fields, and Group 5 is physiotherapists working in the field of public health. planned to occur. Before starting the study, the participants will be asked to fill in the Volunteer and Consent Form that they voluntarily participated in, and then they will be asked to fill out the Personal Information Form, the Extended Nordic Musculoskeletal System Questionnaire, the Pain Coping Inventory, the Maslach Burnout Scale, and the Vocational Satisfaction Scale prepared by us. According to the results obtained, 5 different groups will be compared among themselves by the determined parameters. The surveys to be used will be uploaded to the Google Forms database. Then, the participants will be asked to participate in the study by being reached via online media such as e-mail, mobile phone applications , social media.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
255

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Turkey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

physiotherapists who have been actively working for more than a year

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • Being a physiotherapist
  • Having completed at least 1 year in the profession and continuing an active working life
  • Being between the ages of 21 and 60

Exclusion Criteria:

  • Not having completed 1 year in the profession
  • Having any systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
1.group
patient area in the children's area
Other: Survey
Extended Nordic Musculoskeletal Questionnaire Pain Management Inventory Maslach Burnout Scale Vocational Satisfaction Scale
2.group
patient area in the field of orthopedics and athletes
Other: Survey
Extended Nordic Musculoskeletal Questionnaire Pain Management Inventory Maslach Burnout Scale Vocational Satisfaction Scale
3.group
patient area in neurology and intensive care
Other: Survey
Extended Nordic Musculoskeletal Questionnaire Pain Management Inventory Maslach Burnout Scale Vocational Satisfaction Scale
4.group
general group receiving patients in many fields
Other: Survey
Extended Nordic Musculoskeletal Questionnaire Pain Management Inventory Maslach Burnout Scale Vocational Satisfaction Scale
5.group
physiotherapists working in public health
Other: Survey
Extended Nordic Musculoskeletal Questionnaire Pain Management Inventory Maslach Burnout Scale Vocational Satisfaction Scale

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Extended Nordic Musculoskeletal Questionnaire
Time Frame: 2 days
It is a scale used to determine the extent of pain in the musculoskeletal system. The purpose of this questionnaire is to identify and compare pain and complaints in parts of the body. There is an image showing the 9 parts of the body included in the questionnaire. These body parts; neck, shoulders, back, elbows, hands, waist, hips, knees and feet. The respondents are asked whether they have experienced problems such as pain and discomfort in their body parts in the last 12 months, in the last 4 weeks, and on the day of the assessment, and they are asked to mark this as yes or no.
2 days
Maslach Burnout Scale
Time Frame: 2 days
The scale consists of 22 questions in total. A 5-point Likert scale is used to answer the questions. There are options such as 0- Never, 1- Rarely, 2- Sometimes, 3- Often, 4- Always. Volunteers are asked to tick the appropriate option for each question. The scale has 3 sub-categories. There are 9 items for the emotional exhaustion section, 5 items for the depersonalization section, and 8 items for the personal achievement section. People with high burnout levels are expected to have high scores on the emotional exhaustion section and depersonalization section, and low personal achievement scores. The scores that can be obtained from the subscales range from 0-36 for emotional exhaustion, 0-20 for depersonalization, and 0-32 for personal achievement.
2 days
Vocational Satisfaction Scale
Time Frame: 2 days
There are 20 questions in the scale. A five-point Likert-type rating scale was used for these questions. These ratings are 1. Always, 2. Often, 3. Sometimes, 4. Rarely, 5. Never. Items 1, 2, 3, 5, 6, 7, 8, 12, 13, 15, 16, 17, 18, 20 in the questions "5: Always, 4: Often, 3: Occasionally, 2: Rarely, 1: Never", while the items 4, 9, 10, 11, 14, 19, which make up the Negative items, are reversed; It should be scored as 1: Always, 2: Often, 3: Sometimes, 4: Rarely, 5: Never.
2 days
Pain Coping Inventory
Time Frame: 2 days
It is a scale developed to determine the behavioral and cognitive strategies used by people with chronic pain to cope with this situation. In the original form of the scale, active as pain transformation, distancing and demand reduction; There are six passive sub-dimensions: withdrawal, worry, and rest. There are 22 questions in the scale and evaluation is made according to the 4-point Likert type. The lowest score is between 1 (almost never) and the highest score 4 (very often).
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Uskudar University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Elif SANDIKÇI, Bahçeşehir University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 15, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 17, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 17, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 23, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 17, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 14, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Uskudar57

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings